Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

ENETS Abstract Search

#3569 Outcomes of Streptozotocin (STZ)-based chemotherapy (CT) in patients with advanced pancreatic neuroendocrine tumors (pNETs): Data from the Spanish Taskforce of Neuroendocrine and Endocrine Tumors (GETNE) national registry (R-GETNE)

Introduction: STZ-based CT has been used for advanced pNETs with rapid growth, high tumor load or progression to somatostatin analogues (SSA). Evidence supporting use of STZ-based CT in pNET is mainly retrospective, and there is an unmet need of prospective trials in this setting. We present data from the R-GETNE regarding the use of STZ in spanish centers.

Conference:

Presenting Author:

Authors: Esteban-Villarrubia J, Hernando J, Garcia A, Jimenez-Fonseca P, Teulé A,

Keywords: Streptozotocin, Chemotherapy, pNET, GETNE, R-GETNE,

#3498 Challenges in the inclusion of patients with neuroendocrine and endocrine neoplasms in clinical trials (CTs): How to minimize screening failures (SF)

Introduction: Study coordinators working in a Clinical Trials Unit (CTU) are essential for the optimal development of CTs in oncology. Patients with neuroendocrine neoplasms (NENs) treated in CTs have specific challenges related to the heterogeneity of the disease, making their inclusion and screening process more complex.

Conference:

Presenting Author:

Authors: Perera J, Caparrós J, Hernando J, Garcia A, Esteban-Villarrubia J,

Keywords: Clinical trials unit, neuroendocrine neoplasm, Study coordinators, Screening failure, endocrine tumor, VHIO, Oncology, NET,